Ethicon wound closure

Register to receive a free U.S. Market for Wound and Tissue Management report synopsis and brochure

The wound closure market is experiencing consistent unit sales growth supplemented by device innovation. Common products in the wound closure market, such as sutures, will continue to make up the largest portion of the market. However, growth in the overall market is directly correlated to other factors, such as the aging population, and the increasing occurrence of morbid obesity in the US. As a result, increased procedures like bariatric surgery are becoming more common and are expected to increase in popularity as the overall safety profiles of these procedures improve.

“Improved advanced wound closure devices, such as cyanoacrylate-based tissue adhesives, will gain popularity due to their increased healing capabilities compared to traditional sealants,” explains Dr. Kamran Zamanian, CEO of iData. “The market is expected to grow primarily due to increased use in shallow lacerations where the application of sutures or staples would otherwise be painful. These devices are also used in cosmetic applications to improve results.”

Other key findings from the iData Research report series entitled U.S. Market for Wound and Tissue Management:

Improved Product Efficiency
Improved wound management technology is allowing patients to spend less time in the operating room and shorten recovery time. Products such as staplers, ligating clip appliers, strips and tissue adhesives all aid in reducing the time needed to close a wound during and after surgery. These products have a strong appeal to hospitals not only due to their reasonable costs, but also because their time-saving advantages allow doctors and nurses alike to maximize patient throughput.

Leading Competitors
Ethicon (a Johnson & Johnson company) is the leading competitor in the wound closure market with over 50% market share in the US. Although Ethicon’s products are normally priced higher than the market average, their vast portfolio allows them to offer discounts by bundling their products.

Other notable competitors in the U.S. wound closure device market include Covidien, 3M, Aesculap, Applied Medical, Angiotech, Codman, ComMed, Derma Sciences, DeRoyal, Kimberly Clark, Kells Medical, MedLogic, Sunmedix, Teleflex, among others.

For Further Information
More on the wound closure market in the U.S. can be found in the report series published by iData entitled U.S. Market for Wound and Tissue Management. This report covers the U.S. markets for wound closure, static compression therapy, dynamic compression therapy, advanced dressing, moist dressing, antimicrobial dressing, interactive dressing, non-adherent contact layers, traditional wound dressing, hemostats, tissue sealants, anti-adhesions, and negative pressure wound therapy.

The iData series on the market for wound and tissue management devices covers the U.S., Brazil, China, India, Japan, South Korea, Australia, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at [email protected] for a U.S. Market for Wound and Tissue Management report brochure and synopsis.

About Procedure Tracker
Additional procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: